May 12,2020

Continuity of supply secured during COVID-19 outbreak update (12-05-2020)

In these challenging times, as DFE Pharma, we like to inform you regularly to assure you that we will take all measures to support you and to guarantee the supply of our products to your company. Via this we would like to inform you on the recent developments we see, and how we are working to mitigate the side effects of the COVID-19.

With regard to the business impact, we would like to share the following market developments seen by us and our status:

Production (UPDATED)

  • The latest developments are that a number of countries/regions in the world are step by step lowering the COVID-19 counter measures and to ‘restart’ the respective economies and business activities.
  • Irrespective this ‘relief’ by the different governments in the world, DFE Pharma continues to take necessary actions to mitigate the potential production risks in the most effective way. Meaning that DFE Pharma continues to guarantee its continuity of supply from its production sites in The Netherlands (5), Germany (1), India (2), and New Zealand (2).
  • DFE pharma continues to monitor all COVID-19 developments/counter measures closely, act adequately to overcome any potential disruption in its production and will inform you in a timely manner.

Supply (UPDATED):

  • As you are aware, at the meantime, DFE Pharma has taken all possible actions to cope with the transport/shipping challenges. These actions are paying off, currently we encounter very limited issues with availability of transport/shipping lines, i.e. DFE Pharma can transport your ordered products on time in full and maintains its high levels of supply security.
  • Unfortunately we notice that shipping companies and container terminal companies are charging higher prices than contracted due to the effects of COVID-19 on the global transport industry. This could mean that we need to forward these higher transport costs to our customers.
  • For your information and security. DFE Pharma runs a global network of own warehouses, e.g. in The Netherlands, Germany, USA, India and Japan; and a broad global distributor network, with multiple warehouses from which you can be supplied with DFE Pharma products.
Above measures will allow us to act flexibly within our own supply chain to ensure your delivery.

Overall I would like to assure you, that DFE Pharma is there to support you in the best way possible to safeguard your business continuity. We will keep you updated.

If you have any question or remark, please, do not hesitate to contact me or one of your local DFE Pharma representatives; we are there to help you in these challenging times!

Latest news